These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33841866)

  • 1. Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.
    Roca N; Martinez C; Jatem E; Madrid A; Lopez M; Segarra A
    Clin Kidney J; 2021 Apr; 14(4):1207-1215. PubMed ID: 33841866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes.
    Roca N; Madrid A; Lopez M; Fraga G; Jatem E; Gonzalez J; Martinez C; Segarra A
    Clin Kidney J; 2021 Jul; 14(7):1826-1834. PubMed ID: 34221390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.
    Roca N; Jatem E; Martín ML; Muñoz M; Molina M; Martínez C; Segarra A
    Clin Kidney J; 2021 Feb; 14(2):543-549. PubMed ID: 33623677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome].
    Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Agraz I; Salcedo MT
    Nefrologia; 2014; 34(1):46-52. PubMed ID: 24463862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
    Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
    Chehade H; Parvex P; Poncet A; Werner D; Mosig D; Cachat F; Girardin E
    Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
    Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT
    Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
    Mishra OP; Chhabra P; Narayan G; Srivastava P; Prasad R; Singh A; Abhinay A; Batra VV
    Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil.
    Zen RC; Dominguez WV; Braga I; Dos Reis LM; Jorge LB; Yu L; Woronik V; Dias CB
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
    Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
    Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.
    Sinha A; Bajpai J; Saini S; Bhatia D; Gupta A; Puraswani M; Dinda AK; Agarwal SK; Sopory S; Pandey RM; Hari P; Bagga A
    Kidney Int; 2014 Mar; 85(3):649-58. PubMed ID: 24429405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Response to Corticosteroids Remains a Valid Approach to Initial Management of Children With Idiopathic Nephrotic Syndrome.
    Narla D; Swiatecka-Urban A
    Front Pediatr; 2020; 8():533. PubMed ID: 32984227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
    Srivastava T; Garola RE; Whiting JM; Alon US
    Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
    Jin J; Li YW; He Q
    Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.
    Cambier A; Patey N; Royal V; Gougeon F; Genest DS; Brachemi S; Bollée G; Merlen C; Bonnefoy A; Lapeyraque AL; Troyanov S
    Kidney Int Rep; 2024 Mar; 9(3):661-670. PubMed ID: 38481495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.
    Bock ME; Price HE; Gallon L; Langman CB
    Clin J Am Soc Nephrol; 2013 Aug; 8(8):1304-11. PubMed ID: 23620441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease.
    Weng Q; Zhou Q; Tong J; Jin Y; Liu Y; Yu X; Pan X; Ren H; Wang W; Xie J; Chen N
    Clin Proteomics; 2020; 17():18. PubMed ID: 32514258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
    Tune BM; Mendoza SA
    J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
    Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.